Menstrual Cramps Treatment Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	205 Pages	Coherent Market Insights	May, 2023	CMI18049062

Best Price Guarantee
Price	from $4,500
Length	205 Pages
Publisher	Coherent Market Insights
Published Date	May, 2023
SKU	CMI18049062

Menstrual Cramps Treatment Market, By Drug Class (Analgesics, Anticholinergics, Non-steroidal anti-inflammatory drugs, Haematinics, and Others (Progestins, Among others)), By Type (Primary Dysmenorrhea and Secondary Dysmenorrhea), By Route of Administration (Oral, Injectable, Topical, Intrauterine, and Others (Intrauterine, Among others)), By Dosage Form (Tablet, Capsules, Suspension, and Others (Transdermal Patch, Among others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Menstrual cramps (dysmenorrhea) are throbbing or cramping pains in the lower abdomen. Many women have menstrual cramps just before and during their menstrual periods. Conditions such as endometriosis or uterine fibroids can cause menstrual cramps. Symptoms occurred like aching pain in lower abdomen, a feeling of pressure in belly, pain in hips, lower back, and inner thighs. To treat menstrual cramps, over-the-counter pain relievers such as NSAID’s like ibuprofen (Advil), Naproxen sodium (Aleve) are used. Hormonal antagonists drugs such as MYFEMBREE (Pfizer) also used for the treatment of menstrual cramps.

Market Dynamics

Market players in the market are focusing on ncreasing inorganic strategies such as collaboration for menstrual cramp treatment is expected to drive the the global menstrual cramp market growth over the forecast period. For instance, on April 10, 2018, AbbVie, a global research and development-based biopharmaceutical company, and Neurocrine Biosciences, announced PDUFA (Prescription Drug User Fee Act) for Elagolix in endometriosis-associated pain.. Elagolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist. It is administered orally, and is a short-acting molecule that blocks endogenous GnRH receptors in the pituitary gland.

Increasing prevalence of menstrual cramps is expected to drive the market growth over the forecast period. For instance, on January 14, 2022, article published by MDPI, stated that a study was conducted in Europe’s Romania in prospective, analytical, observational and took place between 7 November 2019 and 30 January 2020. This study included a population of 1720 from five university centers throughout the country. Out of 1,720 participants, 1,349 (78.4%) had dysmenorrhea. The prevalence of dysmenorrhea, ranging from 16% to 91% has been reported. The most widely used drugs were non-steroidal anti-inflammatory drugs, utilized by 741 students (54.9%) has been reported.

Moreover, according to article published by International Journal of Womens Health, a study was conducted in Southern Ethiopia, the prevalence of primary dysmenorrhea among all the female students is 70% of population who reported.

Key features of the study:

This report provides in-depth analysis of the global menstrual cramps treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global menstrual cramps treatment market based on the following parameters company highlights, products portfolio, key highlights, financial performance, and strategies.

Key companies covered as a part of this study include Pfizer Inc., Ingelheim International GmbH., Bayer AG, , Cipla Inc, Teva Pharmaceutical Industries Ltd., Sanofi, Johnson & Johnson Services, Inc., Dr. Reddy’s Laboratories Ltd, Almatica Pharma LLC., F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc, Eisen Pharmaceutical Co. (Pvt.) Ltd., Emcure Pharmaceuticals, AbbVie., Sparsha Pharma International Pvt Ltd, Hope Medicine (Nanjing) Co., Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global menstrual cramps treatments market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global menstrual cramps treatments market

Detailed Segmentation:

Global Menstrual Cramp Treatment Market, By Drug Class:

Analgesics

Anticholinergic

Non-steroidal anti-inflammatory drugs (NSAIDs)

Haematinics

Others (Progestins, Among others)

Global Menstrual Cramp Treatment Market, By Type:

Primary Dysmenorrhea

Secondary Dysmenorrhea

Global Menstrual Cramp Treatment Market, By Route of Administration:

Oral

Injectable

Topical

Others (Intrauterine, Others)

Global Menstrual Cramp Treatment Market, By Dosage Form:

Tablet

Capsules

Suspension

Others (Transdermal Patch, Among others)

Global Menstrual Cramp Treatment Market, By Distribution channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Global Menstrual Cramps Treatment Market, By Region:

North America

By Country:

U.S.

Canada

Latin America

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Europe

By Country:

Germany

U.K.

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific

By Country

China

India

Japan

Australia

South Korea

ASEAN

Rest of Asia Pacific

Middle East

By Country:

GCC

Israel

Rest of Middle East

Africa

By Country/Region:

South Africa

Central Africa

North Africa

Company Profiles

Pfizer Inc.*

Company Highlights

Products Portfolio

Key Highlights

Financial Performance

Strategies

Ingelheim International GmbH PerkinElmer Inc.

Bayer AG

Abbott.

Cipla Inc

Teva Pharmaceutical Industries Ltd.

Sanofi

Johnson & Johnson Services, Inc.

Dr. Reddy’s Laboratories Ltd

Almatica Pharma LLC.

F. Hoffmann-La Roche Ltd

GlaxoSmithKline Plc

Eisen Pharmaceutical Co. (Pvt.) Ltd.

Emcure Pharmaceuticals

AbbVie.

Sparsha Pharma International Pvt Ltd.

Hope Medicine (Nanjing) Co., Ltd

“*” marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Drug Class; Market Snapshot, By Type; Market Snapshot, By Route of administration; Market Snapshot, By Dosage Form; Market Snapshot, By Distribution channel; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Market Attractiveness Analysis; Market Opportunities; Product Launches; Market Trends; Merger, Acquisition, Collaborations; Regulatory Guideline and Compliances; Key Developments; PEST Analysis; Technology Landscape; Pricing Analysis; Brand Analysis; Investments and Funding; Facility Expansions
4. Global Menstrual Cramps Treatment Market- Impact of Coronavirus (Covid-19) Pandemic: Government Initiatives; COVID-19 Epidemiology; Key Developments
5. Global Menstrual Cramps Treatment Market, By Drug Class, 2018–2030, (US$ Million): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Analgesics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Anticholinergics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Non-steriodal anti-inflammatory drugs; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Haematinics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Others (Progestins, Among others); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
6. Global Menstrual Cramps Treatment Market, By Type, 2018 - 2030, (US$ Million): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Primary Dysmenorrhea; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Secondary Dysmenorrhea; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
7. Global Menstrual Cramps Treatment Market, By Route of administration, 2018 - 2030, (US$ Million): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segments Trends; Oral; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Injectable; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Topical; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Others (Intrauterine, Among others); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
8. Global Menstrual Cramps Treatment Market, By Dosage Form, 2018 - 2030, (US$ Million): Tablet; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Capsules; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Suspension; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Others (Transdermal Patch, Among others); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
9. Global Menstrual Cramps Treatment Market, By Distribution channel, 2018 - 2030, (US$ Million): Hospital Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Retail Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Online Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); 10. Global Menstrual Cramps Treatment Market, By Region, 2018 - 2030, (US$ Million); Introduction; Market Share Analysis, By Region, 2023 and 2030 (%); Y-o-Y Growth Analysis, For Region, 2018–2030; Regional Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million); U.S.; Canada; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million); Brazil; Mexico; Argentina; Rest of Latin America; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million); U.K.; Germany; Italy; France; Spain; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million); China; India; Japan; ASEAN; Australia; South Korea; Rest of Asia Pacific; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million); GCC; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million); North Africa; Central Africa; South Africa; 11. Competitive Landscape; Pfizer, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Ingelheim International GmbH; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Bayer AG; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Abbott; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Cipla Inc; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Teva Pharmaceutical Industries Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Sanofi; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Johnson & Johnson Services, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Reddy’s Laboratories Ltd; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Almatica Pharma LLC.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; F. Hoffmann-La Roche Ltd; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; GlaxoSmithKline Plc; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Eisen Pharmaceutical Co. (Pvt.) Ltd; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Emcure Pharmaceuticals; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; AbbVie; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Sparsha Pharma International Pvt Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Hope Medicine (Nanjing) Co., Ltd; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; 12. Section; Research Methodology; About Us; *Browse 33 market data tables and 26 figures on “Global Menstrual Cramps Treatment Market”- Global forecast to 2030